Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCostain Group Regulatory News (COST)

Share Price Information for Costain Group (COST)

Share Price is delayed by 15 minutes
Get Live Data
210.00    -2.00 (-0.94%)
Bid:
208.00
Ask:
210.00
Spread: 2.00 (0.962%)
Market Cap: £559.00m
COST Live PriceLast checked at - London Stock Exchange

Intraday Costain Group Share Chart

Director/PDMR Shareholding

27 Oct 2023 13:00

RNS Number : 5783R
Costain Group PLC
27 October 2023
 

Costain Group PLC

27 October 2023

 

COSTAIN GROUP PLC SCRIP DIVIDEND SCHEME

 

Costain Group PLC (the 'Company') announces that on 27 October 2023, Mr Roger Andrews, being the spouse of Ms Jacqueline de Rojas, Non-executive Director, acquired 93 ordinary shares with a nominal value of 50 pence each in the capital of the Company at the scrip dividend reference price of 56.64 pence per share pursuant to the Company's Scrip Dividend Scheme. Following the share allotment, the total beneficial interest of Ms Jacqueline de Rojas and persons closely associated with her is 12,921 shares, representing 0.005% of the Company's issued share capital.

 

The Notification of Dealing Form set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.

 

Notification of Dealing Form

 

1.

Details of the Person Discharging Managerial Responsibility ("PDMR") / person closely associated with them ("PCA")

a)

Name

ROGER ANDREWS (PCA)

2.

Reason for the notification

a)

Position /status

HUSBAND OF JACQUELINE DE ROJAS (PDMR)

b)

Initial notification / amendment

INITIAL NOTIFICATION

3.

Details of the Issuer

a)

Name

COSTAIN GROUP PLC

b)

LEI code

213800PKIJBZ2EDTKC88

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

 

ORDINARY SHARES OF 50 PENCE EACH

 

ISIN: GB00B64NSP76

b)

Nature of the transaction

PURCHASE OF 93 SHARES ON THE 2023 INTERIM DIVIDEND PAYMENT DATE IN ACCORDANCE WITH THE TERMS AND CONDITIONS OF THE SCRIP DIVIDEND SCHEME

c)

Price(s) and volume(s)

Price(s)

Volume(s)

56.64p

93

 

 

 

d)

Aggregated information

- Aggregated volume

- Price

 

N/A

 

 

e)

Date of the transaction

 

27 OCTOBER 2023

f)

Place of the transaction

 

OUTSIDE A TRADING VENUE

 

 

 

Investors and analysts

Paul Sharma, Costain

paul.sharma@costain.com

+44 (0) 7867 501188

 

Financial media - Headland

costain@headlandconsultancy.com

Andy Rivett-Carnac

+44 (0) 7968 997 365

Charlie Twigg

+44 (0) 7946 494 568

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFEUFSWEDSEDS
Date   Source Headline
25th Jun 202610:25 amRNSDirector/PDMR Shareholding
24th Jun 202610:30 amRNSTransaction in Own Shares
23rd Jun 202610:11 amRNSDirector/PDMR Shareholding
18th Jun 202611:46 amRNSDirector/PDMR Shareholding
18th Jun 20267:00 amRNS-RCostain wins West Winch Housing Road contract
17th Jun 202610:30 amRNSTransaction in Own Shares
10th Jun 20269:27 amRNSTransaction in Own Shares
9th Jun 20263:25 pmRNSHolding(s) in Company
9th Jun 20267:00 amRNSCostain wins place on £700m TfL framework
3rd Jun 202610:30 amRNSTransaction in Own Shares
1st Jun 202610:31 amRNSTotal Voting Rights
27th May 20269:34 amRNSTransaction in Own Shares
22nd May 20261:00 pmRNSDirector/PDMR Shareholding
20th May 20269:55 amRNSTransaction in Own Shares
18th May 20261:51 pmRNSAdditional Listing
18th May 20269:39 amRNSDirector Declaration
14th May 20264:28 pmRNSResult of AGM
14th May 20267:00 amRNSAGM Trading Update
13th May 20265:14 pmRNSHolding(s) in Company
13th May 202610:19 amRNSTransaction in Own Shares
12th May 20264:01 pmRNSHolding(s) in Company
6th May 20269:35 amRNSTransaction in Own Shares
5th May 20262:08 pmRNSDirector/PDMR Shareholding
1st May 20264:08 pmRNSScrip Dividend Reference Price - Replacement
1st May 20269:08 amRNSTotal Voting Rights
30th Apr 20263:17 pmRNSDirector/PDMR Shareholding
29th Apr 202610:14 amRNSTransaction in Own Shares
27th Apr 202612:27 pmRNSScrip Dividend Reference Price
22nd Apr 20265:06 pmRNSDirector/PDMR Shareholding
22nd Apr 202611:48 amRNSTransaction in Own Shares
21st Apr 20265:15 pmRNSHolding(s) in Company
16th Apr 20264:59 pmRNSHolding(s) in Company
15th Apr 20263:16 pmRNSTransaction in Own Shares
15th Apr 20263:05 pmRNSDirector/PDMR Shareholding
14th Apr 20263:29 pmRNSDirector Declaration
13th Apr 202611:20 amRNSDirector/PDMR Shareholding
8th Apr 202610:30 amRNSTransaction in Own Shares
2nd Apr 202611:19 amRNSAnnual Financial Report
1st Apr 202610:30 amRNSTransaction in Own Shares
1st Apr 20269:30 amRNSDirector/PDMR Shareholding
1st Apr 20268:59 amRNSTotal Voting Rights
27th Mar 20263:35 pmRNSAdditional Listing
25th Mar 202610:30 amRNSTransaction in Own Shares
18th Mar 202610:30 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNS-RCostain Secures c.£45m Contract with Severn Trent
10th Mar 20267:01 amRNS£20m Share Buyback Programme
10th Mar 20267:01 amRNS£20m Share Buyback Programme
10th Mar 20267:00 amRNSFinal Results
4th Mar 20268:27 amRNSDirectorate change
3rd Mar 202610:57 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.